Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2003
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105103 Peptide beta-turn mimetic compounds and processes for making them
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105081 Heterocyclic compounds as ligands of the GABAA receptor
06/05/2003US20030105075 Hymenialdisine or derivatives thereof in the manufacture of medicaments
06/05/2003US20030105070 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy
06/05/2003US20030105069 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/04/2003EP1316436A1 Optical information recording medium
06/04/2003EP1316316A1 Preparations for oral administration
06/04/2003EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/04/2003EP1315730A1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives
06/04/2003EP1315729A1 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction
06/04/2003EP1315709A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1232156B1 [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
06/04/2003EP1206248B1 Controlled-release sedative-hypnotic compositions and methods related thereto
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0970084B1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/04/2003EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422272A Pyrrolopyridazine compound
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422256A Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
06/04/2003CN1110498C Triazolo-pyridzine derivatives as ligands for GABA receptors
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/03/2003US6573377 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573263 For improving perception, concentration power, learning power and/ or memory power
06/03/2003US6573258 Photodynamic porphyrin antimicrobial agents
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003US6573218 Fused-benzene derivatives useful as herbicides
06/03/2003CA2275554C Intranasal formulations for treating sexual disorders
05/2003
05/30/2003WO2003044023A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003043960A2 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/29/2003US20030100764 Thioether substituted imidazoquinolines
05/29/2003US20030100756 Treatment of acute or chronic inflammatory diseases
05/29/2003US20030100752 With various substitutents in the 12- and 17-positions of the porphyrin skeleton; atherosclerosis, restenosis
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100550 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
05/29/2003US20030100546 Neuropeptide Y antagonists
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/28/2003EP1314726A1 Novel ester or amide derivatives
05/28/2003EP1313737A1 Novel guanidino derivatives as inhibitors of cell adhesion
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313478A2 Method for treatment of migraine using pde5 inhibitors
05/28/2003EP1313370A2 Fungicidal formulation
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1073659B1 Preparation of alkylthio- and/or arylthio-substituted diketo-diaryl-pyrrolopyrroles
05/28/2003EP1069126B1 Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine a3 receptor compatibilizing agent, and asthmatic remedy
05/28/2003EP1039904B1 Synergistic antimicrobial compositions
05/28/2003EP0960185B1 Photobleaching compositions effective on dingy fabric
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003EP0815090B1 Process for tetraazacycloalkane preparation
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420775A Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/27/2003US6570019 Cationic pyrrolo-pyrrol-derivatives, method for producing them and colorants for keratin fibers, containing these compounds
05/27/2003US6570014 Process for preparing triazolopyrimidine derivatives
05/27/2003US6570012 Derivatives of octahydro-6, 10-dioxo-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, useful for preperation of therapeutically active compounds
05/27/2003US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents
05/27/2003US6569863 Bicyclic heteroamatic compounds useful as LH agonists
05/27/2003US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms
05/22/2003WO2003042990A1 Writable high-capacity optical storage media containing metal complexes
05/22/2003WO2003042216A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003WO2003042210A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042172A2 C-5 modified indazolylpyrrolotriazines
05/22/2003WO2003041660A2 Solubilized topoisomerase poisons
05/22/2003WO2003041653A2 Cytotoxic agents
05/22/2003WO2002083686A3 Processes for large scale production of tetrapyrroles
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003WO2002044168A3 Indole-type inhibitors of p38 kinase
05/22/2003US20030096978 Methods of making porphyrins and related compounds with Lewis acids
05/22/2003US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 573